(Q35799088)

10 August 2017

title

Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's disease (English)

1 reference

10 August 2017

1 reference

1 reference

Michael A Schwarzschild

series ordinal

2

object named as

Michael A Schwarzschild

1 reference

10 August 2017

Anil Kachroo

1

1 reference

10 August 2017

publication date

1 February 2012

1 reference

10 August 2017

1 reference

10 August 2017

volume

71

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

278-282

1 reference

Pathophysiological roles for purines: adenosine, caffeine and urate

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

A short overview on the role of alpha-synuclein and proteasome in experimental models of Parkinson's disease

27 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

27 July 2018

https://api.crossref.org/works/10.1002%2FANA.22630

Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

Preclinical jockeying on the translational track of adenosine A2A receptors

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

Proteasome dysfunction in aged human alpha-synuclein transgenic mice

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292742

25 September 2018

Identifiers

DOI

10.1002/ANA.22630

1 reference

10 August 2017

1 reference

10 August 2017

1 reference